Researchers from the University of Pennsylvania have developed a gene therapy that successfully treats a form of macular degeneration in a canine model. The work sets the stage for translating the findings into a human therapy ...
Mar 5, 2018
0
695
Massive banks of genetic information are being harnessed to shed new light on modifiable health risks that underlie common diseases.
Jan 16, 2018
0
7
Gene therapy holds promise for treating a variety of diseases, including some inherited blinding conditions. But for a gene therapy to be effective, one must know the precise gene responsible for a given individual's disorder ...
Dec 20, 2017
0
7
For decades, scientists have known that blue light will make fruit flies go blind, but it wasn't clear why. Now, a Purdue University study has found how this light kills cells in the flies' eyes, and that could prove a useful ...
Dec 18, 2017
0
309
The Spanish firm Sylentis has developed a compound to treat diseases of the retina including age-related macular degeneration and diabetic retinopathy. The treatment is administered by ophthalmic drops instead of intraocular ...
Dec 13, 2017
0
5
(HealthDay)—Many older patients with age-related macular degeneration (AMD) use personal electronic devices, and most are willing to play a game to monitor vision, according to a study published online Nov. 13 in Clinical ...
Dec 1, 2017
0
11
In a major step forward in the battle against macular degeneration, the leading cause of vision loss among the elderly, researchers at the University of Virginia School of Medicine have discovered a critical trigger for the ...
Nov 27, 2017
0
1386
Images used to educate the public about vision loss due to the leading causes of blindness are not fit for purpose, according to a new study from City, University of London.
Nov 24, 2017
0
18
(HealthDay)—There was a decrease in the five-year risk for age-related macular degeneration (AMD) by birth cohorts throughout the 20th century, according to a study published online Nov. 16 in JAMA Ophthalmology.
Nov 19, 2017
0
1
Results from two early clinical trials show that it may be possible to use human embryonic stem cells as treatment for the dry form of macular degeneration, according to presentations given today at AAO 2017, the 121st Annual ...
Nov 14, 2017
0
12
